Centrus Energy Corp. reported second-quarter 2025 revenue of $154.5 million, beating analysts’ estimates of about $130 million but down from $189 million a year earlier. Adjusted earnings came in at $1.59 a share, almost double consensus forecasts, while net income slipped slightly to $28.9 million from $30.6 million. Gross profit rose 48 percent year on year to $53.9 million. The Maryland-based uranium-enrichment company ended the quarter with $833 million in cash and a contract backlog of $3.6 billion, providing what it called strong liquidity and visibility on future revenue. Operationally, Centrus completed Phase 2 of its High-Assay, Low-Enriched Uranium (HALEU) contract, delivering 900 kilograms of HALEU to the U.S. Department of Energy. The DOE has exercised Option 1a of Phase 3, expected to add about $110 million in revenue through June 2026, extending Centrus’s role in supplying advanced nuclear fuel for next-generation reactors.